Jon focuses on developing and executing worldwide patent strategies for life sciences and pharmaceutical companies. Jon concentrates on building patent portfolios to protect pharmaceutical products, which includes advising clients on portfolio creation and expansion, integrating patent and regulatory exclusivities, and advising on Orange Book listing strategies. He has a track record of success in identifying and executing strategies for late-stage inventions and navigating difficult patent issues. Notable patent portfolios Jon has worked on include Epidiolex, Copiktra, Farydak, Arikayce and Amrix.

Download full bio 


  • Secura Bio Acquires Global Rights to Farydak 

  • Secura Bio Acquires Global Rights to Copiktra 

  • Sixth Street Invests in Blueprint Medicines 

  • Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million 

  • Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million 

  • View all


  • Ohio Northern University
    JD, cum laude, 2010

  • Montana State University
    PhD, Organic Chemistry

  • University of Georgia
    BS, Environmental Resource Science

  • University of Georgia
    BS, Chemistry

Admissions & Credentials

District of Columbia

Registered to practice before the United States Patent & Trademark Office (USPTO)


  • American Intellectual Property Law Association